版本:
中国

BRIEF-Bioscrip provides update on Unitedhealthcare contract

May 30 Bioscrip Inc

* Bioscrip provides update on Unitedhealthcare contract

* Bioscrip Inc - ‍reached an agreement to continue to provide certain core product lines to unitedhealthcare beyond September 30, 2017​

* Bioscrip Inc says company is reiterating its prior guidance for adjusted EBITDA in range of $45.0 million to $55.0 million for full-year 2017

* Bioscrip Inc - ‍with agreement, Bioscrip will retain approximately $35 million of annualized profitable core revenue​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐